Mac.Ro UCM IC Digestive Diseases and Ciberehd, University Hospital Virgen del Rocio, Institute of Biomedicine of Seville, University of Seville, Sevilla, Spain.
Department Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.
Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases (NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also regress liver disease. Weight reductions of ⩾10% can induce a near universal non-alcoholic steatohepatitis resolution and fibrosis improvement by at least one stage. However, modest weight loss (>5%) can also produce important benefits on the components of the NAFLD activity score (NAS). Additionally, we need to explore the role of total calories and type of weight loss diet, micro- and macronutrients, evidence-based benefits of physical activity and exercise and finally support these modifications through established behavioural change models and techniques for long-term maintenance of lifestyle modifications. Following a Mediterranean diet can reduce liver fat even without weight loss and is the most recommended dietary pattern for NAFLD. The Mediterranean diet is characterised by reduced carbohydrate intake, especially sugars and refined carbohydrates (40% of the calories vs. 50-60% in a typical low fat diet), and increased monounsaturated and omega-3 fatty acid intake (40% of the calories as fat vs. up-to 30% in a typical low fat diet). Both TV sitting (a reliable marker of overall sedentary behaviour) and physical activity are associated with cardio-metabolic health, NAFLD and overall mortality. A 'triple hit behavioural phenotype' of: i) sedentary behaviour, ii) low physical activity, and iii) poor diet have been defined. Clinical evidence strongly supports the role of lifestyle modification as a primary therapy for the management of NAFLD and NASH. This should be accompanied by the implementation of strategies to avoid relapse and weight regain.
生活方式干预在治疗非酒精性脂肪性肝病 (NAFLD) 患者时可能有效。体重减轻可降低心血管和糖尿病风险,还可使肝病逆转。体重减轻 ⩾10%可使近普遍的非酒精性脂肪性肝炎消退和纤维化改善至少一个阶段。然而,适度的体重减轻 (>5%)也可以对 NAFLD 活动评分 (NAS) 的成分产生重要的益处。此外,我们需要探讨总热量和减肥饮食类型、微量和宏量营养素、体育活动和锻炼的循证益处的作用,最后通过既定的行为改变模型和技术来支持这些改变,以长期维持生活方式的改变。遵循地中海饮食即使在没有体重减轻的情况下也可以减少肝脏脂肪,是 NAFLD 最推荐的饮食模式。地中海饮食的特点是减少碳水化合物的摄入,尤其是糖和精制碳水化合物 (占总热量的 40%,而典型的低脂饮食为 50-60%),增加单不饱和脂肪和 ω-3 脂肪酸的摄入 (占总热量的 40%作为脂肪,而典型的低脂饮食中占 30% 左右)。电视久坐 (整体久坐行为的可靠标志物) 和体力活动都与心血管代谢健康、NAFLD 和总体死亡率有关。已经定义了一种“三重行为表型”:i) 久坐行为,ii) 体力活动不足,iii) 饮食不良。临床证据强烈支持生活方式改变作为 NAFLD 和 NASH 管理的主要治疗方法。这应该伴随着实施避免复发和体重反弹的策略。